PSDV News Alert Psivida Corp (PSDV) 4.19 02/14/2015 11:56:55

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:56 PM

Psivida Corp (PSDV) 4.19 $PSDV

pSivida FQ2 results
Seeking Alpha - at Seeking Alpha - Fri Feb 06, 6:24AM CST

PSDV: 4.19 (+0.12)

pSivida's (PSDV) CEO Paul Ashton on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 11:55PM CST

PSDV: 4.19 (+0.12)

pSivida misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 3:23PM CST

PSDV: 4.19 (+0.12)

pSivida Corp. Reports Second Quarter FY 2015 Results
Business Wire - Thu Feb 05, 3:00PM CST
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its second quarter ended December 31, 2014.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

pSivida CEO to Present at 17Th Annual BioCEO & Investor Conference February 9
Business Wire - Tue Feb 03, 10:31AM CST
pSivida Corp. (NASDAQ

SDV)(ASX

VA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that Dr. Paul Ashton, President and CEO, will present at the 17th Annual BioCEO & Investor Conference, being held at the Waldorf-Astoria Hotel in New York, Monday and Tuesday, February 9 and 10. Dr. Ashton will make his presentation on Monday, February 9 at 3:30 p.m. EST. A webcast of the presentation will be available at: http://www.veracast.com/webcasts/bio/ceoinves...595311.cfm or at the company's website: www.psivida.com. There will be a webcast replay available one hour after the conclusion of Dr. Ashton's presentation that day and it will be available until May 10, 2015.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

pSivida Corp. Announces Second Quarter Fiscal Year 2015 Financial Results Release Date and Conference Call Information
Business Wire - Fri Jan 30, 7:00AM CST
pSivida Corp. (NASDAQ

SDV) (ASX

VA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its financial results for the second quarter of fiscal year 2015 will be released after the market close on Thursday, February 5, 2015, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

pSivida Reports ILUVIEN(R) Receives Marketing Authorization in Two More EU Countries
Business Wire - Mon Jan 26, 1:05PM CST
pSivida Corp. (NASDAQ

SDV)(ASX

VA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that Finland and Luxembourg have granted marketing authorization to ILUVIEN(R) for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. This brings the total number of EU countries in which ILUVIEN has been approved to 15, with two EU approvals still pending.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

Iluvien sales commence in Portugal
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 11:35AM CST

ALIM: 5.16 (unch), PSDV: 4.19 (+0.12)

pSivida Reports Commencement of ILUVIEN(R) Sales in Portugal
Business Wire - Wed Jan 14, 10:55AM CST
pSivida Corp. (NASDAQ

SDV) (ASX

VA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the sale of ILUVIEN(R) for diabetic macular edema (DME) has begun in Portugal. Also sold in the UK and Germany, ILUVIEN is indicated in the EU for treatment of vision impairment associated with chronic DME insufficiently responsive to available treatments.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

Earnings Review: Free Research Reports on PMFG Inc., pSivida, Quantum Technologies, Raven Industries and RBC Bearings
PR Newswire - Mon Dec 22, 7:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including PMFG Inc. (NASDAQ: PMFG), pSivida (NASDAQ: PSDV), Quantum Technologies (NASDAQ: QTWW), Raven Industries (NASDAQ: RAVN), and RBC Bearings (NASDAQ: ROLL). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
QTWW: 2.96 (-0.04), PSDV: 4.19 (+0.12), RAVN: 21.95 (+0.17), PMFG: 4.71 (-0.07), ROLL: 61.78 (-0.39)

Iluvien cleared in the Netherlands
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 2:28PM CST

ALIM: 5.16 (unch), PSDV: 4.19 (+0.12)

pSivida Reports ILUVIEN(R) Granted Marketing Authorization in the Netherlands
Business Wire - Mon Dec 01, 2:05PM CST
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the Dutch Inspectie voor de Gezondheidszorg (IGZ) has granted marketing authorization to ILUVIEN(R) for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. This marks the 14th country in which ILUVIEN has been approved for commercialization.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

pSivida CEO to Present at LD Micro Investor Conference
Business Wire - Wed Nov 26, 7:00AM CST
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that Dr. Paul Ashton, president and chief executive officer, will present at the upcoming LD Micro Conference, being held at the Luxe Hotel in Los Angeles on December 3, at 12 noon PST. His presentation will be webcast at http://wsw.com/webcast/ldmicro7/psdv. An archive of the presentation will be available for 90 days.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

Psivida (PSDV) Upgraded From Sell to Hold
at The Street - Fri Nov 21, 8:22AM CST
Psivida (PSDV) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
PSDV: 4.19 (+0.12)

pSivida Reports ILUVIEN(R) Granted Marketing Authorization in Ireland
Business Wire - Mon Nov 17, 10:48AM CST
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the Irish Health Products Regulatory Authority (HPRA) has granted marketing authorization to ILUVIEN(R) for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. This marks the 13th country in which ILUVIEN has been approved for commercialization.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

pSivida Reports ILUVIEN(R) Granted Marketing Authorization in Belgium
Business Wire - Wed Nov 12, 6:33AM CST
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the Belgian Federal Agency for Medicines and Health Products (FAMHP) has granted marketing authorization to ILUVIEN(R) for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. This marks the 12th country in which ILUVIEN has been approved for commercialization.
PSDV: 4.19 (+0.12), PVA: 7.14 (+0.24)

pSivida ups earnings 657% in FQ1
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:33AM CST

PSDV: 4.19 (+0.12)

pSivida (PSDV) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Fri Nov 07, 7:25AM CST

PSDV: 4.19 (+0.12)

pSivida EPS of $0.67
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:17AM CST

PSDV: 4.19 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wagner Logistics Gears Up for Major Expansion in Liberty

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Jaguar Promise Tackles College Cost for Texas Students

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Trial for Former OB/GYN Arthur Park Begins in Bakersfield

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Navigating Battery Compliance for AI Data Centers

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Omega Point's MCP Secures Anthropic Verification

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Montesodi 2023: A Fresh Chapter in Chianti Excellence

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Truck Drivers USA & Career Driver Unveil New Driver Agent

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...